Patents by Inventor Joseph Marcello Custodio

Joseph Marcello Custodio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190151307
    Abstract: The disclosure describes methods for the treatment of patients co-infected with a virus and tuberculosis (TB), wherein the patient receives a therapeutically effective amount of tenofovir alafenamide (TAF) and a therapeutically effective amount of an antimycobacterial agent such as rifampin (RIF).
    Type: Application
    Filed: October 23, 2018
    Publication date: May 23, 2019
    Inventor: Joseph Marcello Custodio
  • Patent number: 9463194
    Abstract: The disclosure describes methods for treatment of patients co-infected with HIV and tuberculosis, wherein the patient receives effective amounts of elvitegravir, an antimycobacterial agent and a CYP inhibitor.
    Type: Grant
    Filed: February 4, 2015
    Date of Patent: October 11, 2016
    Assignee: Gilead Sciences, Inc.
    Inventors: Rebecca Restituto Begley, Joseph Marcello Custodio, Brian P. Kearney
  • Publication number: 20150216873
    Abstract: The disclosure describes methods for treatment of patients co-infected with HIV and tuberculosis, wherein the patient receives effective amounts of elvitegravir, an antimycobacterial agent and a CYP inhibitor.
    Type: Application
    Filed: February 4, 2015
    Publication date: August 6, 2015
    Inventors: Rebecca Restituto Begley, Joseph Marcello Custodio, Brian P. Kearney